---
title: "MASP2"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene: MASP2"
tags: ['MASP2', 'lectinpathway', 'complementactivation', 'geneticvariants', 'diseaseassociation', 'treatmentoptions', 'prognosis', 'drugresponse']
---

## Gene: MASP2

Function: This gene encodes for Mannan-binding lectin serine protease 2, which is a component of the lectin pathway of complement activation that is triggered by certain glycosylated pathogens.

External IDs and Genomic Location: 
- HGNC: 6973
- NCBI Entrez: 10747
- Ensembl: ENSG00000180210
- OMIM: 154550
- UniProtKB/Swiss-Prot: O00187
- Genomic location: Chromosome 1q21.3

Aliases: MAP19, MASP-2, MASP2D

AA mutation list and mutation type with dbSNP ID:
- NM_001242802.1:c.184C>T (p.Leu62Phe) rs61747659
- NM_139126.5:c.208G>A (p.Asp70Asn) rs28991087
- NM_001242802.1:c.221G>C (p.Ala74Pro) rs750045331

Somatic SNVs/InDels with dbSNP ID: None reported.

Related Disease: Mutations in MASP2 have been found to be associated with several diseases, including susceptibility to infections, asthma, and autoimmune disorders.

Treatment and Prognosis: Treatment options depend on the underlying disease and severity of the symptoms. Prognosis may also vary according to the specific disease associated with MASP2 mutations.

Drug Response: Currently, there is no specific drug therapy targeting MASP2 mutations.

Related papers:
- Subject: Mutations in the lectin pathway of complement activation â€“ report from the first International Complement Genetics Conference
- Author: Peter Garred
- DOI link: 10.1016/j.molimm.2013.06.001

- Subject: Genetic variants in the MASP2 gene are associated with asthma risk in a northeastern Han Chinese population
- Author: Jianjun Dong et al.
- DOI link: 10.1016/j.anai.2017.04.013

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**